Similar effects were also observed in a mouse model of cerebral malaria in which treatment with IFNβ increased the survival rate of the mice and improved the blood-brain barrier function, but it did not alter the systemic parasitemia of Plasmodium berghei (59). Here, IFNB1 is linked to parasitic infectious disease.